The president of HCA Mountain Division, Gregory "Greg" Angle has more than three decades of experience in the healthcare industry. To prepare for his career, Greg Angle earned a master of health services administration from Arizona State University.
Arizona State University (ASU) recently broke ground on a new medical building on its Phoenix campus through a partnership with the Mayo Clinic, a leader in research and patient care. The Health Future Center will help develop entrepreneurs, biomedical professionals, and students into future leaders in the health-care profession. Its premises will comprise 150,000 square feet and house an education zone, nursing programs, biomedical informatics and engineering research labs, and the recently-implemented MedTech Accelerator program. A cooperative venture by ASU and the Mayo Clinic, the MedTech Accelerator furnishes early-stage health-care IT and medical-device companies with personalized business plans. The Health Future Center will open toward the end of 2020. The relationship between ASU and the Mayo Clinic began more than 16 years ago through the introduction of the Mayo Clinic and Arizona State University Alliance for Health Care. The two organizations have also collaborated on research projects, dual-degree programs, joint faculty appointments, and a nursing education program.
0 Comments
With a master’s degree in health services administration from Arizona State University, Gregory “Greg” Angle serves as the president of HCA’s Mountains Division, a system of health care facilities located throughout Idaho, Utah, and Alaska. Committed to involvement in the healthcare management field outside of his everyday work, Greg Angle maintains membership with the American Hospital Association (AHA), a professional organization that provides support and advocacy for hospitals.
In July 2019, the AHA reported on new guidance from the U.S. Food and Drug Administration (FDA) containing draft provisions for medication labeling for drugs that carry the inherent risk of abuse or addiction/dependence. Currently, many of these drugs carry warnings and usage instructions that are overly complicated. Some of the suggested changes include simplifying complex medical terminology and setting clear definitions for terms such as abuse, addiction, and physical dependence. Additionally, the guidance instructs specific labels for opioid medications that provide instructions on how health care providers can taper down dosage in patients who have become dependent. The eventual goal for this practice would be a dose that helps control pain but doesn’t lend itself to greater use/abuse. The FDA also wants providers to develop visual instructions and information for these patients concerning risks and other important factors. |
Archives
January 2020
Categories
All
|